Laboratorios Farmaceutocos Rovi SA (ROVI) EUR0.06
Sell:€50.20Buy:€50.85
€0.95
(1.85%)
- This stock can be held in a
Stocks and Shares ISA€0.95
(1.85%)€0.95
(1.85%)Company Information
About this company
Laboratorios Farmaceuticos ROVI SA (ROVI) is a Spain-based company principally engaged in the pharmaceutical industry. The Company’s main activities include the development and commercialization, nationwide and abroad, of medicines and drugs. Its products are structured into three fields: Diagnostic, which offers contrast mediums for use in magnetic resonance, ultrasound and X-ray diagnostics; Prescription, which distributes medicines under such brands as Hibor, Osseor, Hepadren, Pneumovax-23, Glufan, Corlentor, Exxiv, Calcio y Vitamina D3 Rovi and Absorcol, among others; and Over The Counter (OTC), which comprises the Perspirex, Enerzona, Dentimelo and ColdPack brands. The Company owns such fully consolidated subsidiaries as Gineladius SL, Frosst Iberica SA, Rovi Contract Manufacturing SL and Bertex Pharma GmbH, among others.
Key people
Key facts
- EPICROVI
- LocationSpain
- SectorHealthcare
- IndustryBiotechnology & Drugs
- ISINES0157261019
- Market cap€2.64bn
- Employees2,179
- Shares in issue51.24m
- ExchangeMercado Continuo Espana
- IndexIBEX 35 Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.